...T cell responses by excluding any T cell epitopes from tau and instead inducing a tau-independent...
...still coming.The semorinemab news was the first major blow the tau hypothesis, which maintains that tau...
...target intracellular and extracellular tau? AC Immune’s vaccine will test the former; its small molecule tau...

...protein hypothesized to misfold in the brains of Alzheimer’s patients, contributing to the misfolding of tau...

...week 78. Submit new correlation analysis.Possible workaround 2: Submit more data on other biomarkers, particularly tau...

...an SGK1 antagonist tool compound improved performance on those behavioral tests and lowered levels of phosphorylated tau...
...leukemia protein (MLL1; MLL; HRX; KMT2A); serum/glucocorticoid regulated kinase 1 (SGK1); microtubule-associated protein τ (tau; MAPT; FTDP-17)EXPERIMENTAL...

...adds a second PET agent to image tau...
...we’ve seen that if they don’t have tau...
...trial, Lilly sought patients with a “Goldilocks tau”...

...tau-targeting Alzheimer’s disease candidate. Two were optimistic.While tau...
...big Alzheimer’s target behind amyloid, the first tau...
...target. Another issue is whether the forms of tau...

...can include structures that contain DNA; may comprise only one type of biomolecule, as in tau...
...Ventures, Invus, Catalio Capital Management, Casdin Capital and Alexandria Venture InvestmentsCEO: Cary PfefferPatents: UndisclosedTARGETStau  (MAPT; FTDP-17...

...the misfolding and aggregation of the protein tau...
...think Biogen should correlate changes in phosphorylated tau...

...in Alzheimer's disease. Selina, you've been following tau...
...I know you've written a lot about tau...
...of tau antibodies, and other types of tau...

...decrease tau aggregation as measured by PET imaging.“Tau...
...tau, based on the hypothesis that misfolded tau...
...MAPT; FTDP-17) – Microtubule-associated protein tau Selina Koch Genentech Inc. AC Immune S.A. Microtubule-associated protein tau (tau) (MAPT) (FTDP-17) Neurology Alzheimer's...